Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahash Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled clinical trials by the Natilnao Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and Natilnao Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer tnsIitute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have cntributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled cliical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement i survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III rkandomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research kand Treatment of Cancer EORTC kand National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment xof Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Counscil MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institte NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P
Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel Project NSABP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal P|Large multi-centric bPhase III randomised controlled clinical trials by the National Surgical Adjuvant Breast Bowel bProject NSABbP Medical Research Council MRC the European Organisation for Research and Treatment of Cancer EORTC and National Cancer Institute NCI have contributed significantly to the improvement in survivalWatson Ian R Takahashi Koichi Futreal bP
